John Tabor

718 citations
10 papers · 623 · 1 hit paper · h-index 3

Impact in

Papers in

    • Animal Genetics and Reproduction 2
    • Bacterial Genetics and Biotechnology 2
    • CRISPR and Genetic Engineering 2
    • Viral Infectious Diseases and Gene Expression in Insects 1

John Tabor

5 papers receiving 447 citations

John Tabor's Hit Papers

Human leukocyte interferon produced by E. coli is biologically active 1980 · 467 citations
4670+15+30Years since publication100200300400

Peers

John Tabor
Comparison fields: 5 of 72
  • Immunology 265
  • Radiology, Nuclear Medicine and Imaging 167
  • Oncology 152
  • Molecular Biology 263
  • Biotechnology 26
Replace P Valsasnini with:
P Valsasnini Italy
G. W. Litman United States
Annette Schmitz France
Paola Delmastro Italy
Larry W. Arnold United States
Karin Pfeifer Germany
Andrea C. Becker Germany
Brian Ondek United States
R A Gatti United States
Ivy Suzuki United States
John Tabor relative to P Valsasnini Italy P Valsasnini's profile →
Citations per field
00.5×2×3×4×
P Valsasnini · 1×
Citations per year

Countries citing papers authored by John Tabor

Since Specialization
Citations

This map shows the geographic impact of John Tabor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Tabor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Tabor more than expected).

Fields of papers citing papers by John Tabor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Tabor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Tabor. The network helps show where John Tabor may publish in the future.

Co-authors

The 25 scholars most cited alongside John Tabor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Tabor Line = papers co-authored together John Tabor links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1
Human leukocyte interferon produced by E. coli is biologically active
Hit paper breakdown →
1980467
2 1980108
3 200742
4 19772
5
A realistic dream - A top-down feasibility study for MEMS planetary exploration
20052
6 19791
7
Genetic Engineering Technology in Industrial Pharmacy: Principles and Applications
19881
8 20180
9 19850
10
Development beyond the Central City: Eco-infrastructure in Ulcinj, Montenegro
20090

About John Tabor

John Tabor is a scholar working on Genetics, Molecular Biology, Ecology, Epidemiology and Global and Planetary Change, having authored 10 papers that have together received 623 indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (2 papers), Animal Genetics and Reproduction (2 papers), Bacterial Genetics and Biotechnology (2 papers), Bacteriophages and microbial interactions (2 papers), CRISPR and Genetic Engineering (2 papers), Modular Robots and Swarm Intelligence (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper) and Forest Ecology and Biodiversity Studies (1 paper). The work is most often cited by research in Immunology (265 citations), Radiology, Nuclear Medicine and Imaging (167 citations), Oncology (152 citations), Molecular Biology (263 citations) and Biotechnology (26 citations). John Tabor has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include P C Familletti, Russell McCandliss, Mitchell Gross, Alan Sloma, Shuichiro Maeda, Sidney Pestka, N. Stebbing, Thomas J. Dull, Herbert L. Heyneker and Axel Ullrich. Their work appears in journals such as Gene, Forest Ecology and Management, Nature, Proceedings of the National Academy of Sciences and Drug Development and Industrial Pharmacy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact